28 March 1996
Cardiac transplantation in Krakow
A Dziatkowiak, M Garlicki, B Kapelak, J Sadowski, T Wysocka, R Pfitzner, E Pietrzyk, S Wojcik, E Flis, P Rudzinski, J Nessler, E Ciechanowicz, J Kopacz, W Frasik, B Olszewska, J Siwinska, B Gulla, B ZawilinskaAnn Transplant 1996; 1(1): 46-50 :: ID: 496614
Abstract
In October 1988 the Krakow heart transplantation program was initiated at the Cardiac and Vascular Surgery Department, Institute of Cardiology. Until December 1995, 137 patients, 114 male and 23 female have undergone primary orthotopic heart transplantation (Figure 1). The recipients' age ranged from 9 to 68years, the majority of patients were between 43 and 53 years old. Three children were grafted at 9,15,16 years of age respectively.
Keywords: Heart Transplantation, rejection control, prophylaxisof infections
In Press
Original article
Fundamental Strategies and Technical Perspectives in Bile Duct Anastomosis for Living Donor Liver Transplan...Ann Transplant In Press; DOI: 10.12659/AOT.953761
Clinical Research
Retrospective Study of Implementation and Outcomes of a Non-Cryopreserved Autologous Hematopoietic Stem Cel...Ann Transplant In Press; DOI: 10.12659/AOT.954230
Clinical Research
Prognostic Prediction in Living Donor Liver Transplantation Recipients With Complete Pathological Response ...Ann Transplant In Press; DOI: 10.12659/AOT.954574
Most Viewed Current Articles
24 Aug 2021 : Review article 21,978
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 18,247
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 16,856
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
05 Apr 2022 : Original article 16,762
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604